Athos announces research collaboration to advance precision medicine in inflammatory bowel disease
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
The appointments will add to the well-diversified experience that currently exists on the PPL board.
LifeWell Raises USD 80M from OrbiMed to Build Large Scale Healthcare Delivery Platform with Full stack Diagnostics~
Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Subscribe To Our Newsletter & Stay Updated